Epalrestat: Mechanistic Insights and Research Utility as ...
2026-01-19
Epalrestat is a high-purity aldose reductase inhibitor that offers targeted inhibition of the polyol pathway and direct KEAP1/Nrf2 pathway activation. Its validated neuroprotective and antidiabetic properties enable advanced research in diabetic complication and neurodegenerative disease models. APExBIO delivers Epalrestat with stringent quality control and workflow-ready formulation.